Department of Medicine, Epilepsy Research Centre, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
Epilepsia. 2023 Jul;64(7):1833-1841. doi: 10.1111/epi.17616. Epub 2023 Apr 27.
This study was undertaken to analyze phenotypic features of a cohort of patients with protracted CLN3 disease to improve recognition of the disorder.
We analyzed phenotypic data of 10 patients from six families with protracted CLN3 disease. Haplotype analysis was performed in three reportedly unrelated families.
Visual impairment was the initial symptom, with onset at 5-9 years, similar to classic CLN3 disease. Mean time from onset of visual impairment to seizures was 12 years (range = 6-41 years). Various seizure types were reported, most commonly generalized tonic-clonic seizures; focal seizures were present in four patients. Progressive myoclonus epilepsy was not seen. Interictal electroencephalogram revealed mild background slowing and 2.5-3.5-Hz spontaneous generalized spike-wave discharges. Additional interictal focal epileptiform discharges were noted in some patients. Age at death for the three deceased patients was 31, 31, and 52 years. Molecular testing revealed five individuals were homozygous for c.461-280_677 + 382del966, the "common 1-kb" CLN3 deletion. The remaining individuals were compound heterozygous for various combinations of recurrent pathogenic CLN3 variants. Haplotype analysis demonstrated evidence of a common founder for the common 1-kb deletion. Dating analysis suggested the deletion arose approximately 1500 years ago and thus did not represent cryptic familial relationship in this Australian cohort.
We highlight the protracted phenotype of a disease generally associated with death in adolescence, which is a combined focal and generalized epilepsy syndrome with progressive neurological deterioration. The disorder should be suspected in an adolescent or adult patient presenting with generalized or focal seizures preceded by progressive visual loss. The common 1-kb deletion has been typically associated with classic CLN3 disease, and the protracted phenotype has not previously been reported with this genotype. This suggests that modifying genetic factors may be important in determining this somewhat milder phenotype and identification of these factors should be the subject of future research.
本研究旨在分析长病程 CLN3 病患者的表型特征,以提高对该疾病的认识。
我们分析了 6 个家系的 10 位长病程 CLN3 病患者的表型数据。对 3 个据称无关的家系进行了单倍型分析。
视力损害是首发症状,发病年龄为 5-9 岁,与经典 CLN3 病相似。从视力损害到癫痫发作的平均时间为 12 年(范围为 6-41 年)。报告了各种类型的癫痫发作,最常见的是全面强直阵挛发作;4 例患者存在局灶性癫痫发作。未出现进行性肌阵挛癫痫。发作间期脑电图显示轻度背景减慢和 2.5-3.5-Hz 自发性全面棘波放电。一些患者还存在发作间期局灶性癫痫样放电。3 名已故患者的死亡年龄分别为 31、31 和 52 岁。分子检测显示 5 人纯合 c.461-280_677+382del966,即“常见 1-kb”CLN3 缺失。其余个体均为各种常见致病性 CLN3 变异的复合杂合子。单倍型分析表明,常见 1-kb 缺失存在共同的启动子。约会分析表明,缺失发生在大约 1500 年前,因此在澳大利亚队列中不存在隐性家族关系。
我们强调了一种通常与青少年期死亡相关的疾病的长病程表型,这是一种伴有进行性神经功能恶化的局灶性和全面性癫痫综合征。在出现全面性或局灶性癫痫发作、伴有进行性视力丧失的青少年或成年患者中,应怀疑存在这种疾病。常见的 1-kb 缺失通常与经典 CLN3 病相关,而以前并未报道过这种基因型的长病程表型。这表明修饰性遗传因素可能在决定这种稍轻的表型中起重要作用,确定这些因素应是未来研究的主题。